Newsfeeds - Spark Newswire

1 minute read

Kamada Announces Submission Of Application To US FDA To Manufacture CYTOGAM At Company’s Facility In Israel

Today, 5:03 PM

FDA Approval Currently Expected by Mid-2023 Sales of CYTOGAM® Highest Among Four IgG Products Acquired in November 2021, with Gross Margins Over 50% Ability to Manufacture CYTOGAM at Kamada's Facility to

KMDA

14 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 5:03 PM

On Thursday, 241 companies hit new 52-week lows.

ACHL

1 minute read

Kamada Q3 Adjusted EPS $0.10, Sales $32.22M Beat $29.76M Estimate

By Benzinga Newsdesk

Today, 5:03 PM

Kamada (NASDAQ:KMDA) reported quarterly earnings of $0.10 per share. The company reported quarterly sales of $32.22 million which beat the analyst consensus estimate of $29.76 million by 8.26 percent. This is a 39.87

KMDA

3 minute read

Earnings

Earnings Scheduled For November 22, 2022

By Benzinga Insights

Today, 5:03 PM

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its third quarter.

ADI

1 minute read

Earnings

Kamada: Q2 Earnings Insights

By Benzinga Insights

Today, 5:03 PM

Kamada (NASDAQ:KMDA) reported its Q2 earnings results on Wednesday, August 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Kamada posted an EPS of $-0.09.

KMDA

1 minute read

Kamada Q2 EPS $(0.09) Misses $0.02 Estimate, Sales $23.59M Miss $25.63M Estimate

By Benzinga Newsdesk

Today, 5:03 PM

Kamada (NASDAQ:KMDA) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $0.02 by 550 percent. This is a 550 percent decrease over earnings of $0.02 per share from the same

KMDA

3 minute read

Earnings

Earnings Scheduled For August 17, 2022

By Benzinga Insights

Today, 5:03 PM

Companies Reporting Before The Bell • Children's Place (NASDAQ:PLCE) is expected to report earnings for its second quarter.

ADI

1 minute read

News

Kamada Announces Resolution to the Labor Strike at the Company’s Manufacturing Facility in Israel; New, Eight-Year Collective Agreement Signed

By Bill Haddad

Today, 5:03 PM

Kamada Ltd. (NASDAQ:KMDA) (KMDA.TA), a vertically integrated global biopharmaceutical company, focused on specialty plasma-derived therapeutics, announced today that the Company, the Employees' Union of Kamada's

KMDA

3 minute read

The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer’s Drug Due In January, FDA Reviews Roche’s Lymphoma Candidate, Rare Pediatric Tag For Kazia’s Pediatric Brain Cancer Candidate

By Vandana Singh

Today, 5:03 PM

Here's a roundup of top developments in the biotech space over the last 24 hours:

AMTI

2 minute read

Kamada Announces $11.4M Agreement To Supply VARIZIG To An Undisclosed International Organization

By Bill Haddad

Today, 5:03 PM

Procurement Agreement Following a New Tender Won from an International Organization Operating Principally in Latin America Product Supply Expected During

EBS